Freedom Cannabis To Acquire Boaz Pharma

Freedom Cannabis Inc., a Canadian producer of cannabis products, has signed a definitive agreement to acquire the assets of Calgary-based Boaz Pharmaceuticals Inc. The details of the agreement were not disclosed.

With 126,000 square feet of cultivation and manufacturing space, the Boaz assets are expected to double the production capacity of Freedom's existing facility and provide entrance into cannabis 2.0 products. The Boaz assets consist primarily of 44 specially repurposed shipping containers equipped with new technologies to produce superior quality crops and higher yields. The containers provide opportunities for scalability and ease of installation and allow for expansion of new cannabis strains. Each container is expected to hold approximately 850 cannabis plants and yield approximately 40,000 grams.

Key Transaction Highlights:

  • The containers are outfitted with technology which will increase yields and lower operating costs to contribute to cost efficiencies.

  • Boaz has a series of cannabis 2.0 products which will be integrated and expanded upon to provide diversification in Freedom's product offering to retail consumers. In addition, Boaz has an extensive catalog of cannabis strains with the ability to supply those strains to customers.

  • The transaction will deliver additional EBITDA to shareholders through synergies and other strategic initiatives.

  • The principal shareholders of Boaz have committed to investing $1.8 million into Freedom Cannabis providing the Company additional working capital and demonstrating Boaz's commitment to Freedom Cannabis.

"This is an exciting step toward our vision of expanding the scale of our quality cannabis products, while contributing to overall shareholder value," stated Johnfrank Potestio, CEO of Freedom Cannabis. "Boaz has a demonstrated history of producing quality craft cannabis and will integrate seamlessly with our own products."

The acquisition will provide Freedom Cannabis with additional packaging equipment for the company's fast-growing services division, additional growing capacity to meet the rising demand for retail products across Canada and secure a foothold into the cannabis 2.0 market.

Additionally, Freedom will acquire all inventory for Boaz and product SKUs currently offered throughout Canada, including in provinces currently not served by Freedom Cannabis, particularly in the Maritimes where Boaz has a strong market presence.

Freedom Cannabis will also be acquiring important intellectual property assets, including IP associated with Boaz's extracts division and K-Cup product which is a cannabis-infused coffee drink.

"This acquisition demonstrates our commitment to revenue growth and increasing shareholder value," continued Potestio. "Freedom Cannabis is quickly becoming one of the most well recognized and respected brands in the cannabis sector, and the acquisition of Boaz is another step in that direction."

Photo by Tim Foster on Unsplash

Related News

Freedom Cannabis Forms Strategic Alliance With Artizen

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMarketsBoaz Pharmaceuticals Inc.Freedom Cannabis Inc.Johnfrank Potestio
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...